• HOME
  • Business
  • Stock
  • Property
  • Market
  • Economy
  • Crypto
Language:
×
  • Home
  • tags Fujifilm Diosynth Biotechnologies

Fujifilm Diosynth Biotechnologies News

Business

Regeneron and Fujifilm Forge $3B Biotech Alliance to Enhance US Pharmaceutical Production

Michael Lee 23 Apr, 2025

Regeneron Pharmaceuticals Inc. has signed a $3 billion deal with Fujifilm Diosynth Biotechnologies to produce biologic medicines in North Carolina, marking a significant investment...

Popular News

  • Economy

    Hassett Predicts Resolution of Trade Uncertainties by Early April, Boosting US Economy

    10 Mar, 2025
  • Market

    Oil Prices Tumble Over 3% Amid Tariff Tensions: A Deep Dive into Market Reactions

    05 Feb, 2025
  • Business

    Air India Eyes Massive Fleet Expansion with 30-40 New Wide-Body Jets from Airbus and Boeing

    20 Mar, 2025
  • Business

    IndiGo Expands US Reach with Four New Codeshare Routes via Istanbul

    17 Dec, 2024
  • Business

    MobiKwik's Spectacular Trading Debut: Shares Surge 85%, Valuation Hits Rs 40 Billion

    18 Dec, 2024
  • Market

    Dow Jones, Nasdaq 100, and S&P 500 Futures Dip Amid Tariff Turmoil and Earnings Reports

    12 Feb, 2025
  • Market

    European Automakers Face Stock Plunge as U.S. Imposes Hefty Tariffs on Foreign Cars

    27 Mar, 2025
  • Business

    Porsche-Piech Family Pushes for VW Plant Closures to Cut Costs

    18 Dec, 2024

Newsletter

Subscribe Newsletter!

Stay ahead of the market – subscribe now for the latest insights and expert analysis delivered straight to your inbox!

About Us

  • EconWatcher.com is a comprehensive financial website dedicated to providing insights into economics, stocks, real estate, cryptocurrencies, markets, and business trends.
  • 15 Cliff St, New York NY 10038, USA
  • +91 234 567 8765
  • [email protected]

Popular Categories

  • Business (1M+)
  • Stock (1M+)
  • Property (1M+)
  • Market (1M+)
  • Economy (1M+)
  • Crypto (1M+)

Legal

  • Privacy Policy

  • Terms & Conditions

  • Contact Us

Copyright © 2022 All Rights Reserved.